FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W785204982> ?p ?o ?g. }

• W785204982 endingPage "90" @default.
• W785204982 startingPage "81" @default.
• W785204982 abstract "Despite recent improvements, resistance to traditional immunotherapy or chemotherapy is still common in patients with bladder cancer. We constructed an oncolytic virus from herpes simplex virus type II (HSV-2), which selectively targets tumor cells with an activated Ras signaling pathway. We evaluated the antitumor effect of this oncolytic HSV-2 (FusOn-H2) against bladder cancer, and compared with that of a first generation oncolytic virus derived from HSV-1 (Baco-1).We established bladder tumor at the orthotopic site in C3H/He mice using the MBT-2 cells. Baco-1 or FusOn-H2 was instilled into the bladder through the urethra respectively. Tumor volume and weight were recorded by the end of the experiment. Animal spleens were also collected to determine if any anti-tumor immunity was elicited during virotherapy in this syngeneic bladder cancer model.Two instillations of the oncolytic HSVs into bladder of tumor-bearing mice almost completely eradicated the tumor in majority of tumor bearing mice. The results of tumor-specific cytotoxic T lymphocyte activity assay showed that tumor destruction by oncolytic viruses in vivo, especially by the FusOn-H2, induced potent anti-tumor immune responses.Oncolytic virus derived from HSV-2 has potent anti-tumor activity against bladder cancer. Oncolytic effect of this virus in vivo induces tumor specific cellular immunity that further enhances the overall anti-tumor activity. Translating this novel virotherapy into the clinic could present an alternative intravesical therapy strategy for patients with bladder cancer." @default.
• W785204982 created "2016-06-24" @default.
• W785204982 creator A5015005766 @default.
• W785204982 creator A5018595476 @default.
• W785204982 creator A5037316372 @default.
• W785204982 creator A5048604566 @default.
• W785204982 date "2015-04-30" @default.
• W785204982 modified "2023-10-18" @default.
• W785204982 title "Therapeutic Effect on Bladder Cancer with a Conditionally Replicating Oncolytic Virus Derived from Type II Herpes Simplex Virus" @default.
• W785204982 cites W124239641 @default.
• W785204982 cites W1495408999 @default.
• W785204982 cites W1533379125 @default.
• W785204982 cites W1571033777 @default.
• W785204982 cites W1760402415 @default.
• W785204982 cites W1965840858 @default.
• W785204982 cites W1970212185 @default.
• W785204982 cites W1974763195 @default.
• W785204982 cites W1979135796 @default.
• W785204982 cites W1983989072 @default.
• W785204982 cites W1988700867 @default.
• W785204982 cites W1997306903 @default.
• W785204982 cites W2002951980 @default.
• W785204982 cites W2040543332 @default.
• W785204982 cites W2043103956 @default.
• W785204982 cites W2045148061 @default.
• W785204982 cites W2061034474 @default.
• W785204982 cites W2067497413 @default.
• W785204982 cites W2074114618 @default.
• W785204982 cites W2087183910 @default.
• W785204982 cites W2090732350 @default.
• W785204982 cites W2091526073 @default.
• W785204982 cites W2098599594 @default.
• W785204982 cites W2105879003 @default.
• W785204982 cites W2110355622 @default.
• W785204982 cites W2111765784 @default.
• W785204982 cites W2115804513 @default.
• W785204982 cites W2118851550 @default.
• W785204982 cites W2120109646 @default.
• W785204982 cites W2124221114 @default.
• W785204982 cites W2134391698 @default.
• W785204982 cites W2135430110 @default.
• W785204982 cites W2140997748 @default.
• W785204982 cites W2142563643 @default.
• W785204982 cites W2145674988 @default.
• W785204982 cites W2155606973 @default.
• W785204982 cites W2164846640 @default.
• W785204982 cites W2171950183 @default.
• W785204982 cites W2325605933 @default.
• W785204982 cites W2412492782 @default.
• W785204982 cites W61550010 @default.
• W785204982 doi "https://doi.org/10.3233/blc-150013" @default.
• W785204982 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6218184" @default.
• W785204982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30561438" @default.
• W785204982 hasPublicationYear "2015" @default.
• W785204982 type Work @default.
• W785204982 sameAs 785204982 @default.
• W785204982 citedByCount "3" @default.
• W785204982 countsByYear W7852049822021 @default.
• W785204982 countsByYear W7852049822022 @default.
• W785204982 countsByYear W7852049822023 @default.
• W785204982 crossrefType "journal-article" @default.
• W785204982 hasAuthorship W785204982A5015005766 @default.
• W785204982 hasAuthorship W785204982A5018595476 @default.
• W785204982 hasAuthorship W785204982A5037316372 @default.
• W785204982 hasAuthorship W785204982A5048604566 @default.
• W785204982 hasBestOaLocation W7852049821 @default.
• W785204982 hasConcept C121608353 @default.
• W785204982 hasConcept C126322002 @default.
• W785204982 hasConcept C154317977 @default.
• W785204982 hasConcept C159047783 @default.
• W785204982 hasConcept C202751555 @default.
• W785204982 hasConcept C203014093 @default.
• W785204982 hasConcept C2522874641 @default.
• W785204982 hasConcept C2777283488 @default.
• W785204982 hasConcept C2777701055 @default.
• W785204982 hasConcept C2780352672 @default.
• W785204982 hasConcept C2781196997 @default.
• W785204982 hasConcept C49744831 @default.
• W785204982 hasConcept C502942594 @default.
• W785204982 hasConcept C55493867 @default.
• W785204982 hasConcept C71924100 @default.
• W785204982 hasConcept C82210918 @default.
• W785204982 hasConcept C86803240 @default.
• W785204982 hasConcept C8891405 @default.
• W785204982 hasConceptScore W785204982C121608353 @default.
• W785204982 hasConceptScore W785204982C126322002 @default.
• W785204982 hasConceptScore W785204982C154317977 @default.
• W785204982 hasConceptScore W785204982C159047783 @default.
• W785204982 hasConceptScore W785204982C202751555 @default.
• W785204982 hasConceptScore W785204982C203014093 @default.
• W785204982 hasConceptScore W785204982C2522874641 @default.
• W785204982 hasConceptScore W785204982C2777283488 @default.
• W785204982 hasConceptScore W785204982C2777701055 @default.
• W785204982 hasConceptScore W785204982C2780352672 @default.
• W785204982 hasConceptScore W785204982C2781196997 @default.
• W785204982 hasConceptScore W785204982C49744831 @default.
• W785204982 hasConceptScore W785204982C502942594 @default.
• W785204982 hasConceptScore W785204982C55493867 @default.

• next